A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Compositions and Methods for SARS‑CoV‑2 Vaccines
WO 2021155323 A1 Published: 2021Assignees: Janssen Pharmaceutica NV / Johnson & JohnsonFocus: Vaccines based on recombinant adenovirus serotype 26 (Ad26) vectors encoding SARS‑CoV‑2 spike proteins for preventing or reducing COVID‑19 infection. What This Patent Covers This patent…
-
Compositions and Methods for Controlling Cellular Identity
WO2021202564A1 What This Patent Covers This patent application claims intellectual property around technologies that can influence and control a cell’s identity — meaning how a cell maintains its specialized function or state (for example, a…
-
Development and demonstration of Cas13‑based antiviral CRISPR strategy
Published in: Cell (2020) What This Study Showed This paper demonstrated an innovative CRISPR‑Cas13‑based antiviral approach called PAC‑MAN (Prophylactic Antiviral CRISPR in huMAN cells) that uses an RNA‑targeting CRISPR system to directly degrade viral RNA…
BioTech IP Review 